Neuroblastoma Research and Treatments

TopicLeading institutions, researchers & key papers

This cluster of papers represents a comprehensive exploration of neuroblastoma, covering topics such as genetic mutations (including ALK and MYCN), risk classification, staging systems, immunotherapy, and genomic analysis. The research also delves into therapy strategies and prognosis for patients with neuroblastoma.

282

Works

IDs:OpenAlex

How has Neuroblastoma Research and Treatments's publication output changed over time?

ScholarIQpublication output · 1993–2020

Output grew0% over the shown period — from 1 works in 1993 to 1 in 2020.

1993200120052007200820102013201520182020

What are the most-cited papers on Neuroblastoma Research and Treatments?

ScholarIQmost cited works

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

Susan L. Cohn, Andrew D.J. Pearson, Wendy B. London, Tom Monclair, Peter F. Ambros, Garrett M. Brodeur, Andreas Faldum, Barbara Hero, Tomoko Iehara, David Machin, Véronique Mosseri, Thorsten Simon, Alberto Garaventa, Victoria Castel, Katherine K. Matthay

Journal of Clinical Oncology. 20081,919 Citations

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Isabelle Janoueix‐Lerosey, Delphine Lequin, Laurence Brugières, Agnès Ribeiro, Loïc de Pontual, Valérie Combaret, Virginie Raynal, Alain Puisieux, Gudrun Schleiermacher, Gaëlle Pierron, Dominique Valteau‐Couanet, Thierry Frébourg, Jean Michon, Stanislas Lyonnet, Jeanne Amiel, Olivier Delattre

Nature. 2008896 Citations

Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene.

Ronald E. van Kesteren, Naweed I. Syed, David W. Munno, Jildau Bouwman, Zhong‐Ping Feng, Wijnand P. M. Geraerts, August B. Smit

PubMed. 2001469 CitationsOPEN ACCESS

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

Wenqian Zhang, Ying Yu, Falk Hertwig, Jean Thierry‐Mieg, Wenwei Zhang, Danielle Thierry‐Mieg, Jian Wang, Cesare Furlanello, Viswanath Devanarayan, Jie Cheng, Youping Deng, Barbara Hero, Huixiao Hong, Meiwen Jia, Li Li, Simon Lin, Yuri Nikolsky, André Oberthuer, Tao Qing, Zhenqiang Su, Ruth Volland, Charles Wang, May D. Wang, Junmei Ai, Davide Albanese, Shahab Asgharzadeh, Smadar Avigad, Wenjun Bao, Marina Bessarabova, Murray H. Brilliant, Benedikt Brors, Marco Chierici, Tzu‐Ming Chu, Jibin Zhang, Richard G. Grundy, Min He, Scott J. Hebbring, Howard L. Kaufman, Samir Lababidi, Lee Lancashire, Yan Li, Xin X. Lu, Heng Luo, Xiwen Ma, Baitang Ning, Rosa Noguera, Martin Peifer, John H. Phan, Frederik Roels, Carolina Rosswog, Susan Shao, Jie Shen, Jessica Theißen, Gian Paolo Tonini, Jo Vandesompele, Po-Yen Wu, Wenzhong Xiao, Joshua Xu, Weihong Xu, Jiekun Xuan, Yong Yang, Zhan Ye, Zirui Dong, Ke Zhang, Ye Yin, Chen Zhao, Yuanting Zheng, Russell D. Wolfinger, Tieliu Shi, Linda H. Malkas, Frank Berthold, Jun Wang, Weida Tong, Leming Shi, Zhiyu Peng, Matthias Fischer

S81160022. 2015430 CitationsOPEN ACCESS

Molecular targeting therapies for neuroblastoma: Progress and challenges

Atif Zafar, Wei Wang, Gang Liu, Xinjie Wang, Wa Xian, Frank McKeon, Jennifer H. Foster, Jia Zhou, Ruiwen Zhang

S22382660. 2020397 CitationsOPEN ACCESS